Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medical devices integrating cationic steroidal antimicrobial compounds

A medical device, anti-microbial technology, applied in the field of medical devices to achieve the effect of reducing inflammation, reducing contamination of implants, and reducing the risk of infection

Inactive Publication Date: 2018-07-17
BRIGHAM YOUNG UNIV
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

While less severe cases of subglottic stenosis can be corrected with endoscopic laser surgery, more severe cases require reconstruction with cartilage grafts and stents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical devices integrating cationic steroidal antimicrobial compounds
  • Medical devices integrating cationic steroidal antimicrobial compounds
  • Medical devices integrating cationic steroidal antimicrobial compounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] To determine the role of synthetic seraginines CSA-13, 44 and 90 in inflammation, mesenchymal stem cells (MSCs), targeted mRNA panels from SABiosciences and primary cells from Lonza were used. Cells were purchased from Lonza.com and used fresh for each test, using recommended media and culture conditions. After processing, use Qiagen RNeasy Mini Isolate mRNA and use NanoDrop Purity was quantified by UV at 260 nm and 260 / 280 ratio. Using First Strand from SABiosciences cDNA was prepared and real-time PCR was performed using a kit from the same company for selective analysis of wound healing pathways. The q-PCR results were uploaded to SABiosciences website and Ingenuity.com website for analysis and pathway drawing. On day 1, primary human cells were cultured using 6-well plates with 3 ml of the recommended medium - hMSCBasal Medium + BulletKit (50 ml Growth Supplement, 10 ml L-Glutamine, and 0.5 ml Gentamicin Sulfate Amphotericin-B). MSC cells were plated at a den...

Embodiment 2

[0082] IL-6 is a marker of systemic inflammation. A nonlethal dose of Pseudomonas aeruginosa (P. aeruginosa) was used to infect the respiratory tract of female C57 / BL6 mice as a pneumonia model. One cohort (n=6) also received 80 mg / kg CSA-13; the second cohort (n=6) also received 40 mg / kg CSA-13; the third cohort (n=6) did not receive CSA treatment; the fourth cohort ( n=6) Not infected. Examination of IL-6 levels in kidneys 24 hours post-infection revealed that those infected animals without CSA treatment had IL-6 levels >15-fold that of controls and 5-10-fold higher than those in CSA-treated animals. Thus, treatment with CSA significantly reduced renal IL-6 levels in a pneumonia model.

Embodiment 3

[0084] Silicone-based Foley catheters were coated with an approximately 10 μm thick hydrogel coating. Coatings include CSA-131. Initially, the coating was shown to maintain efficacy for about 6 or 7 days.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to View More

Abstract

This disclosure relates to medical devices incorporating one or more cationic steroidal antimicrobials (CSAs). The CSAs are incorporated into the medical devices to provide effective antimicrobial, anti-inflammatory, and / or tissue-healing properties. A medical device includes a component formed from a polymeric material. One or more CSA compounds are mixed with the polymeric material so that the one or more CSA compounds are incorporated into the structure of the medical device as formed from the polymeric material. A medical device can additionally or alternatively include a lubricious coating containing one or more CSA compounds.

Description

technical field [0001] The present disclosure relates generally to medical devices, including implantable medical devices in particular, which incorporate one or more cationic steroidal antimicrobial (CSA) compounds to provide antimicrobial activity, anti-inflammatory activity, pain relief, and increased rate of tissue healing one or more of. Background technique [0002] Medical devices include instruments that are used on the body of a subject for diagnostic or therapeutic purposes. In use, many medical devices are implanted in a subject, either as permanent implants or as temporary implants. However, even when strict sterilization procedures are followed, such medical implants can be subject to microbial contamination (e.g., biofilm formation). When biocontamination of an implant occurs, the implant must be removed from the subject. After contamination, medical devices are generally not suitable for further use and must be discarded. Often, contaminated implants must ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K49/04A61K51/04
CPCA61M39/08A61L29/085A61K31/575A61L29/16A61M16/0465A61L2400/10A61L2300/404A61L2300/41A61L2300/606A61M2205/0205A61M2205/0238A61M2207/00A61P29/00A61L29/06A61L29/08A61M25/0017A61L29/145A61L2300/222A61M2025/0056A61M25/00
Inventor 卡尔·吉尼伯格保罗·B·萨维奇罗纳德·L·布拉肯
Owner BRIGHAM YOUNG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products